-
Virender Kumar，Vandana Garg，Harish Dureja（Department of Pharmaceutical Sciences,Maharshi Dayanand University,Rohtak）.Nanoemulsion for delivery of anticancer drugs[J].Cancer Advances,2022,第8期
-
Ahmed Lateef Alkhaqani.Advancing oncology nursing practice:a vital and changing role[J].Cancer Advances,2022,第8期
-
Yu-Feng Huang，Jing Xiang，Chun Yuan Chen，Biao Deng，Xia Yang，Lian-Xiang Luo，Zhu Liang（GuangdongChina.）.Autophagy-associated long non-coding RNA signature for lung adenocarcinoma[J].Cancer Advances,2022,第8期
-
Melika Amelimojarad，Mandana AmeliMojarad（Department of Molecular Biology）.Circ-ADAM9:a novel biomarker in human cancers[J].Cancer Advances,2022,第8期
-
Zi-Hong Wu，Zi-Ming Wang，En-Feng Song，Bei Yin（Affiliated Hospital of Chengdu University of Traditional Chinese Medicine；Department of Traditional Chinese Medicine, Renmin Hospital of Wuhan University；The Second Clinical Medical College of Guangzhou University of Chinese Medicine）.To explore the mechanism of anticancer prescription in treatment of gastric cancer based on network pharmacology and molecular docking[J].Cancer Advances,2022,第8期
-
Xun Sun，Bing Dai（Laizhou Hospital of Traditional Chinese Medicine）.Case analysis of epithelioid hemangioendothelioma of pancreas with liver and lung involvement[J].Cancer Advances,2022,第8期
-
Wen-Qi Han（Shandong University of Traditional Chinese Medicine）.Development history of hysteromyoma surgery with uterus preservation and introduction to each operation[J].Cancer Advances,2022,第8期
-
B.Namratha Sai Reddy，Nishith Vaddeboina，Ch.Shyny Reddy（Department of Medical Oncology, Omega Hospitals, Hyderabad）.A puzzling case of differentiation syndrome mimicking SARS-CoV2 pneumonitis: a case report[J].Cancer Advances,2022,第8期
-
Chen-Chen Zhao，Tong Wu，Xian-Bin Kong，Chuan-Xin Liu，Yang Luo，Jian-Hua Duan，Zhu-Ting Li（Departments of Oncology,Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine；Tianjin Traditional Chinese Medicine Rehabilitation Centre；Departments of Cardiology,Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine；College of Traditional Chinese Medicine,Tianjin University of Traditional Chinese Medicine；Department of Metabolism and Endocrinology,Endocrine and Metabolic Disease Center；The First Affiliated Hospital and College of Clinical Medicine of Henan University of Science and Technology；Medical Key Laboratory of Hereditary Rare Diseases of Henan；Luoyang Sub-center of National Clinical Research Center for Metabolic Diseases）.Meta-analysis of therapy of Kang’ai injection combined with chemotherapy in the treatment of non-small cell lung cancer[J].Cancer Advances,2022,第8期
-
Peng-Shuai Wu，Hong-Yang Liu，Meng-Ying Leng，Hai-Guang Zhao（Department of Plastic Surgery,Qilu Hospital of Shandong University；School of Nursing,Yanbian University）.The perceptions and experiences of advanced cancer patients and their families in advance care planning:a systematic review and synthesis of qualitative studies[J].Cancer Advances,2022,第8期
-
Xiang-Yu Deng，Shao-Hua Zhou，Cheng-Han Zhou，Li-Feng Meng（Department of Nephrology,The First Affiliated Hospital,Guangxi University of Traditional Chinese Medicine）.Research progress of uremic myopenia in traditional Chinese and western medicine[J].Cancer Advances,2022,第8期
-
Virender Kumar，Davinder Kumar，Naveen Khatri，Ashwani Kumar，Joginder Khurana（HaryanaIndia.；Department of Pharmaceutical Sciences,Vishwavidyalaya,Jagjeetpur,Haridwar；Tirupati Wellness Ltd.,FH57+7Q7,Puruwala Santokhgarh）.Effect of Chinese herbal medicine on lung disease:an updated review[J].Cancer Advances,2022,第8期
-
Qiu-Hua Li，Zhao-Zhe Liu（Department of Oncology, The Second Hospital of Liaoning University of Chinese Medicine；Department of Oncology, General Hospital of Northern Theater Command）.Research progression on immunotherapy biomarkers of peripheral blood in non-small-cell lung cancer[J].Cancer Advances,2022,第8期
-
Xiao-Meng Wang，Yu Chen（Tianjin Medical University Cancer Institute and Hospital；Department of Cancer Immunotherapy,Tianjin Cancer Hospital Airport Hospital；National Clinical Research Center for Cancer；Key Laboratory of Cancer Immunology and Biotherapy；Tianjin’s Clinical Research Center for Cancer；Key Laboratory of Cancer Prevention and Therapy；Department of Traditional Chinese Medicine,Tianjin Hospital of ITCWM Nankai Hospital）.The expression significance of RACGAP1 gene in hepatocellular carcinoma and its prognostic effect were analyzed based on TCGA database[J].Cancer Advances,2022,第8期
-
Neng-Liang Zhang，Jian-Hua Wang，Wei Cheng，Zheng-Jing Li，Jie Tang，Tao Wang，Yi Chen（Clinical Medical College of Dali University；Department of Oncology,The First Affiliated Hospital of Dali University；Department of Surgery,The First Affiliated Hospital of Dali University）.Primary mucinous carcinoma of the thyroid:case report and review of the literature[J].Cancer Advances,2022,第8期
-
Yu-Xin Wei，Bing-Lin Shi，Huai-Yuan Zheng，An Yan，Xue-Hai Wei，Shi-Bo Zhao，Zi-Hui Liu（College of clinical, Youjiang Medical University for Nationalities；General Surgery, First People's Hospital of Fangchenggang；College of Nursing, Youjiang Medical University for Nationalities；College of Clinical Medicine, Guilin Medical University；Hematology, First People's Hospital of Fangchenggang）.Advances in the exploration of adjuvant therapy of colon cancer with Chinese medicine[J].Cancer Advances,2022,第8期
-
An-Shun Zhang，Jiang-Xia Yin，Chang-Ming Song（Department of pharmacy, Shouguang Hospital of Traditional Chinese Medicine；Department of Medical Oncology, Shouguang Hospital of Traditional Chinese Medicine）.A narrative review on palbociclib for hormone receptor-positive and human epidermal growth factor receptor-2 negative advanced breast cancer[J].Cancer Advances,2022,第8期
-
Zhao Wang，Yue Wang，Zhang-Yi Wang，Chao-Kai He，Xiao-Li Pang（Graduate School of Tianjin University of Traditional Chinese Medicine；Peking Union Medical College Hospital；School of nursing, Tianjin University of Traditional Chinese Medicine）.Peer support improving the life quality of colostomy patients with colorectal cancer[J].Cancer Advances,2022,第8期
-
Shuang Li，Chen-Chen Zhao，Chu-Yi Zhang，Jing-Xuan Li，Wang Gao（Graduate School of Tianjin University of Traditional Chinese Medicine；Department of Oncology,Second Affliated Hospital of Tianjin University of Traditional Chinese Medicine；First Teaching Hospital of Tianjin University of Traditional Chinese Medicine,National Clinical Research for Chinese Medicine Acupuncture and Moxibustion；Department of Gastroenterology,Second Affliated Hospital of Tianjin University of Traditional Chinese Medicine）.Research progress of traditional Chinese medicine monomers in intervening colorectal cancer by regulating MAPK signaling pathway[J].Cancer Advances,2022,第8期
-
Davinder Kumar，Virender Kumar，Harsh Kumar，Aakash Deep，Rakesh Kumar Marwaha（Department of Pharmaceutical Sciences,Maharishi Dayanand University；Department of Pharmaceutical Sciences,Chaudhary Bansi Lal University）.1,3,4-Oxadiazole as an emerging telomerase inhibitor-a promising anticancer motif[J].Cancer Advances,2022,第8期
-
Yun-Chao Zhang，Ling-Li Li，Lei Qin，Bo-Qun Song，Na Lu，Ying Zhang，Huang-Hui Xie，Yao Tang，Shi-Yu Wang，Yu-Tong Zhang（Department of Oncology,First Teaching Hospital of Tianjin University of Traditional Chinese Medicine；Graduate school of Tianjin University of Traditional Chinese Medicine）.A study on the frequency of thyroid nodules and uterine fibroids in Chinese breast cancer patients[J].Cancer Advances,2022,第8期
-
Dan Tian，Ting-Ting Chen，Qing Xu，Xiao-Yu Li，Qian-Zhou Lv（Pharmacy department,Zhongshan Hospital,Fudan University）.Predictive factors for the post embolization fever after transcatheter arterial chemoembolization in hepatocellular carcinoma patients:a single center study in China[J].Cancer Advances,2022,第8期
-
Dillip Kumar Parida，Sandip Kumar Barik，Adhar Amritt，Minakshi Mishra，Poornima Devi，Saroj Kumar Das Majumdar（Department of Radiotherapy, All India Institute of Medical Sciences）.Pandemic adaptation in oncological management-a tertiary care radiation oncology center experience[J].Cancer Advances,2022,第8期
-
Nisarg R Hajariwala，Hinal S Panchal，Nira Amin，Deeksha A Singh（Department of Clinical Pharmacy, HCG Cancer Center, Vadodara；Department of Pharmacy Practice, Parul University, Vadodara）.Effectiveness of total therapy in immune thrombocytopenia purpura: case series[J].Cancer Advances,2022,第8期
-
yun-chao zhang，ling-li li，lei qin，bo-qun song，na lu，ying zhang，huang-hui xie，yao tang，shi-yu wang，yu-tong zhang（Department of Oncology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine；Graduate school of Tianjin University of Traditional Chinese Medicine）.A study on the frequency of thyroid nodules and uterine fibroids in Chinese breast cancer patients[J].Cancer Advances,2022,第7期
-
Zuo-Peng Xiao，Meng-Jun Nie，Xi Zou（The Affiliated Hospital of Nanjing University of Chinese MedicineJiangsu Province Hospital of Chinese Medicine；No.1 Clinical Medical CollegeNanjing University of Chinese Medicine；Jiangsu Provincial Hospital of Integrated Traditional Chinese and Western Medicine）.Rare bullous pemphigoid during PD-1 inhibitor therapy:a case report[J].Cancer Advances,2022,第6期
-
Zi-Hong Wu，Zi-Ming Wang，En-Feng Song，Bei Yin（Affiliated Hospital of Chengdu University of Traditional Chinese Medicine；Department of Traditional Chinese MedicineRenmin Hospital of Wuhan University；The Second Clinical Medical College of Guangzhou University of Chinese Medicine）.To explore the mechanism of anticancer prescription in treatment of gastric cancer based on network pharmacology and molecular docking[J].Cancer Advances,2022,第5期
-
Dillip Kumar Parida，Sandip Kumar Barik，Adhar Amritt，Minakshi Mishra，Poornima Devi，Saroj Kumar Das Majumdar（Department of Radiotherapy All India Institute of Medical Sciences）.Pandemic adaptation in oncological management-a tertiary care radiation oncology center experience[J].Cancer Advances,2022,第4期
-
Xun Sun，Bing Dai（Laizhou Hospital of Traditional Chinese Medicine）.Case analysis of epithelioid hemangioendothelioma of pancreas with liver and lung involvement[J].Cancer Advances,2022,第2期
-
Melika Amelimojarad，Mandana AmeliMojarad（Department of Molecular BiologyKharazmi University）.Circ-ADAM9:a novel biomarker in human cancers[J].Cancer Advances,2022,第1期
|